Update Mediators of Joint Swelling and Damage in Rheumatoid Arthritis and Pristane Induced Arthritis

References

• Bedwell AE, Elson CJ, Carter SD, Dieppe PA, Hutton CW, Czudek R. Isolation and analysis of complement activating aggregates from synovial fluids of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies. Ann Rheum Dis 1987; 46: 55–64
   PubMedGoogle Scholar
• Male DK, Roitt IM. Molecular analysis of complement fixing rheumatoid synovial fluid immune complexes. Clin exp Immunol 1982; 46: 521–529
   Google Scholar
• Rademacher TW. Network theory of glycosylation-etiologic and pathogenic implications of changes in IgG glycoform levels in autoimmunity. Sem Cell Biol 1992; 3
   Google Scholar
• Rook GAW, Thompson SJ, Buckley M, Elson CJ, Brearly R, Lambert C, Whyte A, Rademacher T. The role of oil and agal-actosyl IgG in the induction of arthritis in rodent models. Eur J Immunol 1991; 21: 1027–1032
   PubMed Web of Science ®Google Scholar
• Hitsumoto Y, Thompson SJ, Elson CJ. Relationship between interleukin-6 and pristane induced arthritis. Autoimmunity 1992; 11: 247–254
   PubMed Web of Science ®Google Scholar
• Haragai M, Kitani A, Hara M, Hirose T, Norioka KI, Susuki K. Rheumatoid adherent synovial cells produce Bcelldifferentiation factor activity neutralizable by antibody to Bcellstimulatory factor-2/Interleukin 6. J Rheumatol 1988; 15: 1616–1622
   PubMedGoogle Scholar
• Winchester RJ, Agnello V, Kunkel HG. Gamma globulin complexes in synovial fluid of patients with rheumatoid arthritis. Partial characterisation and relationship to lowered complement levels. Clin exp Immunol 1970; 6: 689–706
   PubMed Web of Science ®Google Scholar
• Zvaifler NJ. Breakdown products of C3 in human synovial fluids. Clin Invest 1969; 48: 1532–1542
   Google Scholar
• Dularay D, Dieppe PA, Elson CJ. Depressed degranulation response of synovial fluid polymorphonuclear leukocytes from patients with rheumatoid arthritis to IgG aggregates. Clin exp Immunol 1990; 79: 195–201
   PubMedGoogle Scholar
• Dularay B, Dieppe PA, Elson CJ. Oxidative response of polymorphonuclear leukocytes to synovial fluids from patients with rheumatoid arthritis. Ann Rheum Dis 1990; 49: 661–669
   PubMedGoogle Scholar
• Dularay B, Elson CJ, Dieppe PA. Enhanced oxidative responses of polymorphonuclear leukocytes from synovial fluids of patients with rheumatoid arthritis. Autoimmunity 1988; 1: 159–169
   PubMedGoogle Scholar
• Allen RE, Blake DR, Nazhat NB, Jones P. Superoxide radical generation by inflamed human synovium and hypoxia. Lancet 1989; ii: 282–283
   Google Scholar
• Bhoola KD, Figeroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharm Rev 1992; 44: 1–80
   PubMed Web of Science ®Google Scholar
• Figeroa CD, Maclver AG, Bhoola KD. Identification of a tissue kallikrein in human polymorphonuclear leukocytes. Brit J Haematol 1989; 72: 321–328
   PubMedGoogle Scholar
• Selwyn BM, Figeroa CD, Fink E, Swan A, Dieppe PA, Bhoola KD. A tissue kallikrein in the synovial fluids of patients with rheumatoid arthritis. Ann Rheurn Dis 1989; 48: 128–133
   PubMedGoogle Scholar
• Figeroa CD, Henderson LM, Kaufman J, De la Cadena RA, Colman RW, Muller-Esterl W, Bhoola KD. Immunovisualis-ation of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils. Blood 1992; 79: 754–759
   PubMedGoogle Scholar
• Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia. Nature NB 1972; 240: 200–203
   Web of Science ®Google Scholar
• Sturge RA, Yates DB, Gordon D, Franco M, Paul B, Bray A, Morley J. Prostaglandin production in arthritis. Ann Rheum Dis 1978; 37: 315–320
   PubMedGoogle Scholar
• Salmon JA, Higgs GA, Vane JR, Bitensky L, Chayen J, Henderson B, Cashman BA. Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining cells in nonproliferative organ cultures. Ann Rheum Dis 1983; 42: 36–39
   PubMedGoogle Scholar
• Rouser CA, Scott WA, Kempe J, Cohn ZA. Prostaglandin synthesis by macrophages requires a specific receptor-ligand interaction. Proc Nat Acad Sci 1980; 77: 4279–4282
   PubMedGoogle Scholar
• Baker DG, Dayer J-M, Roelkr M, Schumacher HR, Krane SM. Rheumatoid synovialcellmorphological changes induced by a mononuclearcellfactor in culture. Arth Rheum 1983; 26: 8–14
   PubMed Web of Science ®Google Scholar
• Burch RM, Connor JR, Tiffany CW. The kallikrein-kinin system in chronic inflammation. Agents action 1989; 27: 258–260
   PubMedGoogle Scholar
• Macmillan RM, Foster SJ. Leukotriene B4 and inflammatory disease. Agents action 1988; 24: 114–119
   PubMedGoogle Scholar
• Fell HD, Jubb RW. The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arth Rheum 1978; 20: 1359–1372
   Google Scholar
• Hollander AP. Criteria for identifying mediators of tissue damage in human autoimmune disease. Autoimmunity 1991; 9: 171–176
   PubMed Web of Science ®Google Scholar
• Melnyck VO, Shipley GD, Sternfeld MD, Sherman L, Rosenbaum JT. Synoviocytes synthesize, bind, and respond to basic fibroblast growth factor. Arth Rheum 1990; 33: 493–500
   PubMedGoogle Scholar
• Chandrasekhar S, Harvey AK. Induction of interleukin-1 receptors on chondrocytes by fibroblast growth factor: a possible mechanism for modulation of interleukin-1 activity. J Cell Physiol 1989; 138: 236–245
   PubMed Web of Science ®Google Scholar
• Phadke K. Fibroblast growth factor enhances interlukein-1 mediated chondrocytic protease release. Biochem Biophs Res Comm 1987; 142: 448–453
   PubMed Web of Science ®Google Scholar
• Hollander AP, Atkins RM, Eastwood DM, Dieppe PA, Elson CJ. Human cartilage is degraded by rheumatoid arthritis synovial fluids but not cytokines in vitro. Clin exp Immunol 1991; 83: 52–57
   PubMed Web of Science ®Google Scholar
• Ismaiel S, Atkins RM, Pearse MF, Dieppe PA, Elson CJ. Susceptibility of normal and arthritic cartilage to degradative stimuli. Brit J Rheumatol 1992; 31: 369–373
   PubMedGoogle Scholar
• Bandara G, Lin CW, Georgescu HI, Evans CH. The synovial activation of chondrocytes: evidence for complex cytokine interactions involving a possible novel factor. Biochem Biophs Acta 1992; 1134: 309–318
   PubMedGoogle Scholar
• Hardingham TE, Bayliss MT, Rayan V, Noble DP. Effects of growth factors and cytokines on proteoglycans turnover in articular cartilage. Brit J Rheumatol 1992; 31: 1–6
   PubMedGoogle Scholar
• Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. [mmunolocalisation of matrix metalloproteinase 3 (stromclysin) in rheumatoid synovioblasts (B cells); correlation with rheumatoid arthritis. Ann Rheum Dis 1989; 48: 645–653
   PubMed Web of Science ®Google Scholar
• Kowanko IC, Ferrante A. Granulocyte-macrophage colony stimulating factor augments neutrophil-mediated cartilage degradation and neutrophil adherence. Arth Rheum 1991; 34: 1452–1460
   PubMed Web of Science ®Google Scholar
• Arend WP, Malyak M, Bigler CF, Janson RW. The biological role of naturally-occurring cytokine inhibitors. Brit J Rheum 1991; 30: 49–52
   PubMedGoogle Scholar
• Gregerson PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arth Rheum 1987; 30: 1205–1203
   PubMed Web of Science ®Google Scholar
• Sanders M., Feldmann M, June CH, McMichael A, Maini R, Simpson E, Woody JN. T-cell targeted immuno-therapy. Immunol Today 1992; 13: 85
   Google Scholar
• Duke O, Panayi GS, Janossy GJ, Poulter LW. An immuno-histological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin exp Immunol 1982; 49: 22–30
   PubMed Web of Science ®Google Scholar
• Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, Maini RN, Feldman M. Persistence of collagen type II-reactive T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Nat Acad Sci 1989; 86: 636–640
   PubMed Web of Science ®Google Scholar
• van Eden W, Thole JER, van der Zee R, Noordzij A, van Emden JDA, Hensen EJ, Cohen IR. Cloning of the mycobac-terial epitope recognised by T lymphocytes in adjuvant arthritis. Nature 1988; 331: 171–173
   PubMed Web of Science ®Google Scholar
• van den Broek MF., van Bruggen MCF, Hogervorst EJM, van Eden W, van der Zee R, van den Berg WB. Protection against streptococcal cell wall induced arthritis by pretreatment with mycobacterial cell wall 65 Da heat shock protein. J Exp Med 1989; 170: 449–466
   PubMed Web of Science ®Google Scholar
• Tsoulfa G, Rook GAW, Bahr GM, Sattar MA, Behbehani K, Young D. Elevated IgG antibody levels to the mycobacterial 65 kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol 1989; 30: 519–527
   PubMed Web of Science ®Google Scholar
• Pope RM, Lovis RM, Gupta RS. Activation of synovial T lymphocytes by a 60 kD heat shock protein in patients with inflamed synovium. Arth Rheum 1992; 35: 43–48
   PubMedGoogle Scholar
• Thompson SJ, Rook GAW, Brearley RJ, van der Zee R, Elson CJ. Autoimmune reactions to heat shock proteins in pristane-induced arthritis. Eur J Immunol 1990; 20: 2479–2484
   PubMed Web of Science ®Google Scholar
• Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 1992; 358: 155–157
   PubMed Web of Science ®Google Scholar
• Deighton CM, Gray JW, Bint AJ, Walker DJ. Anti-proteus antibodies in rheumatoid arthritis same-sex sibships. Brit J Rheu-matol 1992; 31: 241–246
   PubMedGoogle Scholar